Atlas Trials

Pevonedistat With VXLD Chemotherapy for Adolescent/Young Adults With Relapsed/Refractory ALL or Lymphoblastic NHL

Clinical trial NCT03349281 · COMPLETED

Trial details

NCT number
NCT03349281
Sponsor
Julio Barredo, MD
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Refractory Acute Lymphoblastic LeukemiaRelapsed Acute Lymphoblastic Leukemia
Start date
2019-03-25
Primary completion
2021-08-11
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.